Testing effectiveness (Phase 2)Study completedNCT01120821What this trial is testingTreatment of Polycythemia Vera With GleevecWho this might be right forPolycythemia Vera Weill Medical College of Cornell University 36
Testing effectiveness (Phase 2)Study completedNCT00946270What this trial is testingPomalidomide for Myelofibrosis PatientsWho this might be right forPolycythemia VeraThrombocythemia M.D. Anderson Cancer Center 70
Early research (Phase 1)Study completedNCT00910728What this trial is testingStudy to Assess the Safety of AZD1480 in Patients With Myeloproliferative DiseasesWho this might be right forPrimary Myelofibrosis (PMF)Post-Polycythaemia VeraEssential Thrombocythaemia Myelofibrosis AstraZeneca 65
Early research (Phase 1)Active Not RecruitingNCT04041050What this trial is testingA Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative NeoplasmWho this might be right forMyeloproliferative Neoplasm AbbVie 85
Testing effectiveness (Phase 2)Study completedNCT05558696What this trial is testingBomedemstat (IMG-7289/MK-3543) in Participants With Polycythemia Vera (IMG-7289-CTP-203/MK-3543-004)Who this might be right forPolycythemia Vera Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA) 20
Large-scale testing (Phase 3)Active Not RecruitingNCT05210790What this trial is testingRusfertide in Patients With Polycythemia VeraWho this might be right forPolycythemia Vera Protagonist Therapeutics, Inc. 293
Large-scale testing (Phase 3)Study completedNCT01969838What this trial is testingMomelotinib Versus Ruxolitinib in Subjects With MyelofibrosisWho this might be right forPrimary MyelofibrosisPost-Polycythemia Vera MyelofibrosisPost-Essential Thrombocythemia Myelofibrosis Sierra Oncology LLC - a GSK company 432
Large-scale testing (Phase 3)Study completedNCT06002490What this trial is testingEvaluate P1101 in Japanese PV PatientsWho this might be right forPolycythemia Vera (PV) PharmaEssentia Japan K.K. 21
Large-scale testing (Phase 3)Active Not RecruitingNCT05481151What this trial is testingAssess Efficacy, Safety, and Tolerability of P1101 in Adult Patients With PVWho this might be right forPolycythemia Vera PharmaEssentia 111
Large-scale testing (Phase 3)Study completedNCT04173494What this trial is testingMomelotinib Versus Danazol in Symptomatic and Anemic Myelofibrosis Participants (MOMENTUM)Who this might be right forPrimary MyelofibrosisPost-polycythemia Vera MyelofibrosisPost-essential Thrombocythemia Myelofibrosis Sierra Oncology LLC - a GSK company 195
Not applicableLooking for participantsNCT06734637What this trial is testingEfficacy and Safety of Peginterferon in ET and PV.Who this might be right forEssential ThrombocythemiaPolycythemia Vera Zhenya Hong 40
Not applicableStudy completedNCT06752941What this trial is testingLOW-PV ContinuationWho this might be right forPolycythemia Vera FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS 36
Large-scale testing (Phase 3)Study completedNCT02218047What this trial is testingAOP2014 vs. BAT in Patients With Polycythemia Vera Who Previously Participated in the PROUD-PV Study.Who this might be right forPolycythemia Vera AOP Orphan Pharmaceuticals AG 170
Not applicableLooking for participantsNCT06506084What this trial is testingObservational Study on the Use of Ropeginterferon Alfa-2b in Polycythemia Vera (ROPEG-PV)Who this might be right forPolycythemia Vera FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS 429
Testing effectiveness (Phase 2)UnknownNCT04878003What this trial is testingStudy of KRT-232 or TL-895 in Janus Associated Kinase Inhibitor Treatment-Naïve MyelofibrosisWho this might be right forPrimary Myelofibrosis (PMF)Post-Polycythemia Vera Myelofibrosis (Post-PV-MF)Post-Essential Thrombocythemia Myelofibrosis (Post-ET-MF) Kartos Therapeutics, Inc. 52
Testing effectiveness (Phase 2)Looking for participantsNCT05835466What this trial is testingReparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)Who this might be right forMyelofibrosis (PMF)Post Essential Thrombocythemia Myelofibrosis (ET-MF)Post Polycythemia Vera Related Myelofibrosis (PV-MF) Icahn School of Medicine at Mount Sinai 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT05499013What this trial is testingStudy to Assess SLN124 in Patients With Polycythemia VeraWho this might be right forPolycythemia Vera Silence Therapeutics plc 69
Large-scale testing (Phase 3)Study completedNCT02523638What this trial is testingStudy to Assess the Self-administration of AOP2014 Using a Pen, Developed for the Treatment of Polycythemia Vera PatientsWho this might be right forPolycythemia Vera AOP Orphan Pharmaceuticals AG 30
Large-scale testing (Phase 3)Study completedNCT01632904What this trial is testingRandomized Switch Study From Hydroxyurea to Ruxolitinib for RELIEF of Polycythemia Vera Symptoms: The Relief StudyWho this might be right forPolycythemia Vera Incyte Corporation 110
Large-scale testing (Phase 3)Looking for participantsNCT07429266What this trial is testingINTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)Who this might be right forPolycythemia Vera Ono Pharmaceutical Co., Ltd. 250